209
Surgery in AMD
degeneration. Am J Ophthalmol 2000; 130 (4): 419-428.
28. Fujii GY, de Juan E Jr, Pieramici DJ, Humayun MS, Phillips
S, Reynolds SM, Melia M, Schachat AP. Inferior limited
macular translocation for subfoveal choroidal neovascularization
secondary to age-related macular degeneration: 1-year visual
outcome and recurrence report. Am J Ophthalmol 2002; 134
(1): 69-74.
29. Fujii GY, Pieramici DJ, Humayun MS, Schachat AP, Reynolds
SM, Melia M, de Juan E Jr. Complications associated with
limited macular translocation. Am J Ophthalmol 2000; 130 (6):
751-762.
30. Eandi CM, Giansanti F, Virgili G. Macular translocation
for neovascular age-related macular degeneration. Cochrane
Database Syst Rev 2008; (4): CD006928.
31. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhagic and
fibrous complications of age-related macular degeneration. Am J
Ophthalmol 1988; 105 (1): 25-29.
32. Lambert HM, Capone A, Jr., Aaberg TM, Sternberg P, Jr.,
Mandell BA, Lopez PF. Surgical excision of subfoveal neovascular
membranes in age-related macular degeneration. Am J
Ophthalmol 1992; 113 (3): 257-262.
33. Berger AS, Kaplan HJ. Clinical experience with the surgical
removal of subfoveal neovascular membranes. Short-term
postoperative results. Ophthalmology 1992; 99 (6): 969-975.
34. Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR,
Lowe MA. Surgical management of subfoveal choroidal
neovascularization. Ophthalmology 1992; 99 (6): 952-968.
35. Bressler NM. Submacular surgery. Are randomized trials
necessary? Arch Ophthalmol 1995; 113 (12): 1557-1560.
36. Bressler NM, Bressler SB, Hawkins BS, Marsh MJ, Sternberg
P, Jr., Thomas MA. Submacular surgery trials randomized pilot
trial of laser photocoagulation versus surgery for recurrent
choroidal neovascularization secondary to age-related macular
degeneration: I. Ophthalmic outcomes submacular surgery trials
pilot study report number 1. Am J Ophthalmol 2000; 130 (4):
387-407.
37. Conti SM, Kertes PJ. Surgical management of age-related
macular degeneration. Can J Ophthalmol 2005; 40 (3): 341-
351.
38. Ibanez HE, Williams DF, Thomas MA, Ruby AJ, Meredith TA,
Boniuk I, Grand MG. Surgical management of submacular
hemorrhage. A series of 47 consecutive cases. Arch Ophthalmol
1995; 113 (1): 62-69.
39. Wade EC, Flynn HW, Jr., Olsen KR, Blumenkranz MS,
Nicholson DH. Subretinal hemorrhage management by pars
plana vitrectomy and internal drainage. Arch Ophthalmol 1990;
108 (7): 973-978.
40. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage
with tissue plasminogen activator and surgical drainage. Am J
Ophthalmol 1994; 118 (5): 559-568.
41. Grossniklaus HE, Gass JD. Clinicopathologic correlations
of surgically excised type 1 and type 2 submacular choroidal
neovascular membranes. Am J Ophthalmol 1998; 126 (1): 59-
69.
42. Grossniklaus HE, GreenWR. Histopathologic and ultrastructural
findings of surgically excised choroidal neovascularization.
Submacular Surgery Trials Research Group. Arch Ophthalmol
1998; 116 (6): 745-749.
43. Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp
NM, Marsh MJ, Redford M, Schwartz SD, Sternberg P, Jr.,
Thomas MA, Wilson DJ. Surgery for subfoveal choroidal
neovascularization in age-related macular degeneration:
ophthalmic findings: SST report no. 11. Ophthalmology 2004;
111 (11): 1967-1980.
44. Miskala PH, Bass EB, Bressler NM, Childs AL, Hawkins BS,
Mangione CM, Marsh MJ. Surgery for subfoveal choroidal
neovascularization in age-related macular degeneration: quality-
of-life findings: SST report no. 12. Ophthalmology 2004; 111
(11): 1981-1992.
45. Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS,
Lewis H, MacCumber MW, Marsh MJ, Redford M, Sternberg
P, Jr., Thomas MA, Williams GA. Surgery for hemorrhagic
choroidal neovascular lesions of age-relatedmacular degeneration:
ophthalmic findings: SST report no. 13. Ophthalmology 2004;
111 (11): 1993-2006.
46. Childs AL, Bressler NM, Bass EB, Hawkins BS, Mangione CM,
Marsh MJ, Miskala PH. Surgery for hemorrhagic choroidal
neovascular lesions of age-related macular degeneration: quality-
of-life findings: SST report no. 14. Ophthalmology 2004; 111
(11): 2007-2014.
47. Thumann G, Aisenbrey S, Schraermeyer U, Lafaut B, Esser P,
Walter P, Bartz-Schmidt KU. Transplantation of autologous
iris pigment epithelium after removal of choroidal neovascular
membranes. Arch Ophthalmol 2000; 118 (10): 1350-1355.
48. Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H,
Povelka M, Frohner U, Kruger A, Hilgers RD, Krugluger W.
Transplantation of autologous retinal pigment epithelium in eyes
with foveal neovascularization resulting from age-related macular
degeneration: a pilot study. Am J Ophthalmol 2002; 133 (2):
215-225.
49. van Meurs JC, ter AE, Hofland LJ, van Hagen PM, Mooy CM,
Baarsma GS, Kuijpers RW, Boks T, Stalmans P. Autologous
peripheral retinal pigment epithelium translocation in patients
with subfoveal neovascular membranes. Br J Ophthalmol 2004;
88 (1): 110-113.
50. Bindewald A, Roth F, Van MJ, Holz FG. Transplantation
von retinalem Pigmentepithel (RPE) nach CNV-Exzision bei
altersabhängiger Makuladegeneration. Techniken, Ergebnisse
und Perspektiven. Ophthalmologe 2004; 101 (9): 886-894.
51. Aisenbrey S, Lafaut BA, Szurman P, Hilgers RD, Esser P, Walter
P, Bartz-Schmidt KU, Thumann G. Iris pigment epithelial
translocation in the treatment of exudative macular degeneration:
a 3-year follow-up. Arch Ophthalmol 2006; 124 (2): 183-188.
52. Binder S, Krebs I, Hilgers RD, Abri A, Stolba U, Assadoulina
A, Kellner L, Stanzel BV, Jahn C, Feichtinger H. Outcome of
transplantation of autologous retinal pigment epithelium in
age-related macular degeneration: a prospective trial. Invest
Ophthalmol Vis Sci 2004; 45 (11): 4151-4160.
53. Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC,
Jr., Desai U. A technique for retinal pigment epithelium
